D-1125-2017 Class II Terminated
FDA drug recall D-1125-2017 was initiated by Morton Grove Pharmaceuticals, Inc. on Aug 10, 2017 and is designated Class II. Reason for recall: Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product. The recall status is terminated (terminated Sep 13, 2018). Affected quantity: 7332 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 6, 2017
- Initiation Date
- Aug 10, 2017
- Termination Date
- Sep 13, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7332 bottles
Product description
Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.
Reason for recall
Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Code information
Batch #: KH60276, Exp 10/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1125-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026